Individualization of treatment of hyperlipoproteinemic disorders.
D002792:Cholestyramine Resin / Q000627:therapeutic use; D002914:Chylomicrons / Q000097:blood; D002994:Clofibrate / Q000627:therapeutic use; D004036:Diet, Atherogenic; D004347:Drug Interactions; D006801:Humans; D006949:Hyperlipidemias / Q000145:classification / Q000175:diagnosis / Q000188:drug therapy / Q000235:genetics* / Q000628:therapy*; D008074:Lipoproteins / Q000145:classification; D009539:Nicotinic Acids / Q000627:therapeutic use*; D014280:Triglycerides / Q000097:blood
D002914:Chylomicrons; D008074:Lipoproteins; D009539:Nicotinic Acids; D014280:Triglycerides; D002792:Cholestyramine Resin; D002994:Clofibrate